Industry News
Biotechnology Industry News

Intellia’s CRISPR-engineered cell therapy secures FDA orphan drug status after AML trial launch
Intellia's CRISPR-engineered cell therapy secures FDA orphan drug status after AML trial launch klahucik Wed, 03/09/2022 - 16:31
We have achieved peak biotech formation. It’s time for ‘musical chairs’
We have achieved peak biotech formation. It's time for 'musical chairs' aarmstrong Wed, 03/09/2022 - 14:32
Twist’s antibodies to wind up with Kriya’s AAV gene therapies in new pact
Twist's antibodies to wind up with Kriya's AAV gene therapies in new pact klahucik Wed, 03/09/2022 - 10:25
BeiGene’s hematology CMO jumps to steer pipeline changes at Prelude
BeiGene's hematology CMO jumps to steer pipeline changes at Prelude klahucik Wed, 03/09/2022 - 09:04
J&J’s long-acting injectable push barrels forward as it adds 2nd large molecule to Midatech pact
J&J's long-acting injectable push barrels forward as it adds 2nd large molecule to Midatech pact ntaylor Wed, 03/09/2022 - 08:46
Sanofi, scarred by Roche scrap, hits goal in once-weekly hemophilia A trial and plots race to regulators
Sanofi, scarred by Roche scrap, hits goal in once-weekly hemophilia A trial and plots race to regulators ntaylor Wed, 03/09/2022 - 05:10
BioNTech-Regeneron add 3rd tumor type to partnership testing cancer vaccines with Libtayo
BioNTech-Regeneron add 3rd tumor type to partnership testing cancer vaccines with Libtayo mbayer Tue, 03/08/2022 - 10:37
Sanofi deploying $1B to turn France into ‘pioneer mRNA nation’
Sanofi deploying $1B to turn France into 'pioneer mRNA nation' klahucik Tue, 03/08/2022 - 09:53
Creyon joins wave of AI biotechs with $40M to create ‘on demand’ RNA-based medicines
Creyon joins wave of AI biotechs with $40M to create 'on demand' RNA-based medicines klahucik Tue, 03/08/2022 - 08:59
Valneva heads to FDA as durability of chikungunya vaccine holds up in phase 3
Valneva heads to FDA as durability of chikungunya vaccine holds up in phase 3 ntaylor Tue, 03/08/2022 - 08:11
Late-stage biotechs, Kurma has €160M to help you clear the final hurdles in the race to market
Late-stage biotechs, Kurma has €160M to help you clear the final hurdles in the race to market ntaylor Tue, 03/08/2022 - 05:45
Novartis eyes next-gen AAV gene therapies in $1.75B Voyager biobucks pact
Novartis eyes next-gen AAV gene therapies in $1.75B Voyager biobucks pact aarmstrong Mon, 03/07/2022 - 16:53
J&J to celebrate Carvykti nod without Janssen oncology chief as Serge Messerlian nabs Teon CEO job
J&J to celebrate Carvykti nod without Janssen oncology chief as Serge Messerlian nabs Teon CEO job mbayer Mon, 03/07/2022 - 13:40
Microbiotica nabs $67M to push 2 microbiome therapies through clinic
Microbiotica nabs $67M to push 2 microbiome therapies through clinic mbayer Mon, 03/07/2022 - 11:22
Astellas gets safety win for phase 3 menopause drug, setting up US, EU filings
Astellas gets safety win for phase 3 menopause drug, setting up US, EU filings aarmstrong Mon, 03/07/2022 - 10:16
AstraZeneca tacks on another $100M to wrap up over-budget R&D center
AstraZeneca tacks on another $100M to wrap up over-budget R&D center mbayer Mon, 03/07/2022 - 09:18
Death in Alpine’s Keytruda combo trial triggers clinical hold, raises specter of earlier tragedy
Death in Alpine's Keytruda combo trial triggers clinical hold, raises specter of earlier tragedy ntaylor Mon, 03/07/2022 - 09:08
SalubrisBio’s bispecific heart failure drug boosted by $32M cash injection
SalubrisBio's bispecific heart failure drug boosted by $32M cash injection ntaylor Mon, 03/07/2022 - 08:16
vTv CEO resigns 4 months into job after slashing workforce, refocusing pipeline
vTv CEO resigns 4 months into job after slashing workforce, refocusing pipeline klahucik Fri, 03/04/2022 - 08:50
Shionogi’s COVID-19 vaccine matches Pfizer’s Comirnaty in booster trial
Shionogi's COVID-19 vaccine matches Pfizer's Comirnaty in booster trial ntaylor Fri, 03/04/2022 - 08:40

